Embarc

Leadership

Naveen Yalamanchi, MD

SPACs
2
$100M
Biopharma
HSAC
  1. Registration
  2. IPO
  3. Definitive Agreement
  4. Completed
Completed
Health Sciences Acquisitions Corporation
Immunovant
IMVT207%
Healthcare
HSAQ
  1. Registration
  2. IPO
  3. Definitive Agreement
  4. Completed
Completed
Health Sciences Acquisitions Corp 2
Orchestra BioMed, Inc.
OBIO57%